Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

laboratoires thea - desametasone - desametasone

Italia - italiano - Ministero della Salute

vetoquinol sa - clotrimazolo, desametasone, marbofloxacina - marbofloxacina - 3 mg; clotrimazolo - 10 mg; desametasone - nd, clotrimazolo - 10 mg; desametasone - 0.9 mg; marbofloxacina - 3 mg - dexamethasone and antiinfectives

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - lenalidomidum - capsule rigide - lenalidomidum 2.5 mg, cellulosum microcristallinum, lactosum 33.2 mg, carmellosum natricum conexum corresp. natrium 0.089 mg, magnesii stearas, kapselhülle: gelatina, titanii dioxidum, e 172 (flavum), e 132, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - lenalidomidum - capsule rigide - lenalidomidum 5 mg, cellulosum microcristallinum, lactosum 66.4 mg, carmellosum natricum conexum corresp. natrium 0.178 mg, magnesii stearas, kapselhülle: gelatina, titanii dioxidum, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - lenalidomidum - capsule rigide - lenalidomidum 7.5 mg, cellulosum microcristallinum, lactosum 99.7 mg, carmellosum natricum conexum corresp. natrium 0.266 mg, magnesii stearas, kapselhülle: gelatina, titanii dioxidum, e 172 (flavum), drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - lenalidomidum - capsule rigide - lenalidomidum 10 mg, cellulosum microcristallinum, lactosum 132.9 mg, carmellosum natricum conexum corresp. natrium 0.355 mg, magnesii stearas, kapselhülle: gelatina, titanii dioxidum, e 172 (flavum), e 132, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - lenalidomidum - capsule rigide - lenalidomidum 15 mg, cellulosum microcristallinum, lactosum 199.3 mg, carmellosum natricum conexum corresp. natrium 0.539 mg, magnesii stearas, kapselhülle: gelatina, titanii dioxidum, e 132, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - lenalidomidum - capsule rigide - lenalidomidum 20 mg, cellulosum microcristallinum, lactosum 265.8 mg, carmellosum natricum conexum corresp. natrium 0.716 mg, magnesii stearas, kapselhülle: gelatina, titanii dioxidum, e 172 (flavum), e 132, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - lenalidomidum - capsule rigide - lenalidomidum 25 mg, cellulosum microcristallinum, lactosum 332.2 mg, carmellosum natricum conexum corresp. natrium 0.894 mg, magnesii stearas, kapselhülle: gelatina, titanii dioxidum, drucktinte: lacca, e 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. - onkologikum - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

i.b.n. savio s.r.l - desametasone - desametasone